Search clinical trials for: Sham Comparator:
Total 0 results
Nothing found
Sponsors and Collaborators
- AlpinARC
- Centro Universitário Franciscano
- the people hospital of Linzhi
- Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
- Glasgow Western Infirmary
- Hospitales Universitarios Virgen del Rocío
- Sahachat Aueyingsak
- ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
- Dr Philippe METELLUS
- The Australia-Israel Scientific Exchange Foundation (AISEF)
- Sublimity Therapeutics Holdco Limited
- ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
- Daniela Pacella - University of Naples Federico II, Naples
- Åke Wibergs Stiftelse
- National Institute of Cardiovascular Diseases, Bangladesh
- Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
- IRCCS Istituto Auxologico Italiano, Milano, Italy
- Bassam Abdulkarim
- ECMC
- Etan Orgel
- View Full List
Medical Conditions
- Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
- Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
- Degenerative Spondylolisthesis G1
- Orthopaedic Disorders
- Adult Patients Undergoing Surgery That Requires General Anesthesia
- Pancreaticoduodenectomy
- Very Long Chain Acyl Coa Dehydrogenase Deficiency
- Value-Based Health Insurance
- Eosinophil Blood Count
- Transitional Cell Carcinoma of Renal Pelvis
- Initiation of Depo-Provera (DMPA)
- Patients With Leptomeningeal Disease
- Progression to PD-1 Antibody
- Panniculectomy
- Hyperprolinemia
- Legal History
- Ability to Swim 100m Independent Freestyle
- Interviews
- Bladder Cancer TNM Staging Primary Tumor (T) T2B
- Genetic Risk Factor
- View Full List
Drug Interventions
- Omeprazole 20mg
- Gefitinib
- Epirubicin hydrochloride
- Nimotuzumab
- Metoclopramide + dexamethasone
- 0% N2O
- Erythropoietin
- IV rtPA (intravenous recombinant plasminogen activator)
- Injectable Insulin
- Cefuroxime 750mg oral
- 6% hetastarch
- Mepivacaine
- UFUR and Iressa
- ASP8062
- ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
- Antibiotic treatment
- Prasugrel
- HBM4003 and Triprilimab
- 5-Fluoro-uracil
- Paliperidone palmitate
- View Full List
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Croatia
- Contract Research Organizations in Denmark
- Contract Research Organizations in Gabon
- Contract Research Organizations in Germany
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Guinea
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Malawi
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Turkmenistan
- Contract Research Organizations in Vietnam
- CRO list by country